Generate a tailored SOP for Dr. Saar Gill. Improve your application with a focused, well-structured draft.
Professor Saar Gill focuses on the development of innovative CAR T-cell therapies, particularly for blood cancers and solid tumors. His research encompasses the exploration of CAR therapies in acute myeloid leukemia and the use of CRISPR-edited bone marrow transplants. Gill leads projects currently in early phase clinical trials, aiming to transform cancer immunotherapy. With a strong emphasis on novel approaches, his lab strives to push the boundaries of existing therapeutic options and enhance the efficacy and safety of treatments available for patients.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.